Navigation Links
Nightingale announces US$12.3 million sale of its Therapist Helper business
Date:2/29/2008

h Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at http://www.sedar.com.

The TSX Venture Exchange Inc. has not reviewed and does not accept

responsibility for the adequacy or accuracy of this release.


'/>"/>
SOURCE Nightingale Informatix Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nurture by Steelcase Wins Nightingale Award for Opus(TM) Overbed Table
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...TORONTO, Jan. 8 /PRNewswire-FirstCall/ - Med-Emerg... of Canada,s leading providers of health services,... voted in favour of the previously announced plan ... Group Inc. ("AIM") at a special meeting of MedEme... of 90% of the votes cast at the meeting were in f...
(Date:1/8/2009)...ALEXANDRIA, Va., Jan. 8 ...rganization along with several national leadership...ing the principles of hospice care and protection ... standing together in sharing this unified message...on of Hospice and Palliative Medicine, Hospice and...
(Date:1/8/2009)...California Assembly Member Tom Torlakson Introduce...ire-USNewswire/ -- Today, Lung Cancer Alliance-C...ber Tom Torlakson (D-11th District) for his contin...g funding for lung cancer research. For the third...g cancer research is being considered in the Calif...
(Date:1/8/2009)...ew says it lowered bad cholesterol more effectivel...hDay News) -- After nearly a year of review, U.S. ... the continued use of the controversial cholestero...ug Administration said there was no significant di...nts taking Vytorin and patients taking the drug Zo...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2
...to ten, identified colours and even dabbled with F...an IQ test that her soaring brainpower was establi...e youngest female celebrated member of Mensa. The ...chief executive and a carpenter, Georgia has been ...
...nteers are participating in a six-day long rally h...drug trafficking. Adorning characteristic yellow...e streets of Imphal to send across the message on ...ugs. Over 350 cyclists and 200 volunteers are part...
...merican Journal of Gastroenterology, indicates tha...nd 304 patients has confirmed that polyethylene (...chronic constipation, even elderly patients can us... Until recently, few data were available regardin...
...bly heavier than others. Researchers at the US Na...se Control and Prevention and the Cincinnati Chil...ormones could be contributing to such a phenomenon...children with autism have very rapid head growth i...
Other Medicine News:Health News:Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius 2Health News:Autism Could Be Related to Higher Level of Growth Hormones 2
(Date:1/7/2009)...IS, Jan. 7 Eli Lilly and...eceived a complete response letter from,the U.S. ...long-acting,injection (LAI) for acute and mainten...is continuing to work with the agency on the new d...require any additional clinical trials for the con...
(Date:1/7/2009)..., Jan. 7 ImQuest Life Sciences ann...pplication to the Food and Drug Administration to ...midinedione HIV inhibitor IQP-0410. ImQuest antici...t quarter of 2009. IQP-0410 is a novel small molec...nucleoside reverse transcriptase inhibitor (NNRTI)...
(Date:1/7/2009)...gland, January 7 Circassia Ltd, a ...lergy and critical care, today,announced that fol...8 with,its ToleroMune(R) anti-allergy technology,...t for a further phase II clinical trial in cat all... recruited 120 patients with confirmed,cat allerg...
(Date:1/6/2009)... Jan. 6 In recent controlled studi...f Memphis , scientists found that the patented ing...st and only proven ingredient to increase levels o...g blood nitrate/nitrate (NOx) in human subjects. ,...es an increase in blood flow to the skeletal muscl...
Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2IBT Laboratories Expands its Menu of Tests for Immune Deficiency 3525 1IBT Laboratories Expands its Menu of Tests for Immune Deficiency 3525 2These shells dont clam up 3A Innovative technique to record human impact on coastal waters 6127 1EIN News Introduces Brain Cancer News Today 3B Website Offers Information on Risk Factors Treatment Drugs 31054 1EIN News Introduces Brain Cancer News Today 3B Website Offers Information on Risk Factors Treatment Drugs 31054 2Gene which protects against lung cancer identified 31049 1Gene which protects against lung cancer identified 31049 2
...ELS, Belgium and KOS, Greece, June 29, 2007 /PRNew... updated data for,previously treated patients on R...one shows median survival of 35 months, nearly,thr...mized,controlled Phase III trials that enrolled mo...s worldwide. These updated results,were presented ...
... Presentation of efficacy trends from ongoing phas... ESMO for presentation in,press conference , MARTI...ny,MediGene AG (Frankfurt, Prime Standard: MDG) an...al trial of MediGene,s cancer killing,virus will b...pean,Society for Medical Oncology. Out of more tha...
Other Medicine Technology:The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference 2
Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut
An easy to use uncomplicated ophthalmoscope.
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame.
Halberg Trial Clips have become a required addition to every refractive stand., ,These useful and inexpensive clips may be fitted over your patient's spectacle frame. Each cell has space for thre
Medicine Products: